Skip to main content
PMC home page
PLOS ONE logoLink to PLOS ONE
. 2016 Apr 26;11(4):e0154345. doi: 10.1371/journal.pone.0154345

Association between Triglyceride to HDL-C Ratio (TG/HDL-C) and Insulin Resistance in Chinese Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Xingxing Ren 1,‡, Zengai Chen 2,‡, Shuang Zheng 1,‡, Tingting Han 1, Yangxue Li 1, Wei Liu 1, Yaomin Hu 1,*
Editor: Jianping Ye3
PMCID: PMC4846162  PMID: 27115999

Abstract

Objectives

To explore the association between the triglyceride to HDL-C ratio (TG/HDL-C) and insulin resistance in Chinese patients with newly diagnosed type 2 diabetes mellitus.

Methods

Patients with newly diagnosed type 2 diabetes mellitus (272 men and 288 women) were enrolled and divided into three groups according to TG/HDL-C tertiles. Insulin resistance was defined by homeostatic model assessment of insulin resistance (HOMA-IR). Demographic information and clinical characteristics were obtained. Spearman’s correlation was used to estimate the association between TG/HDL-C and other variables. Multiple logistic regression analyses were adopted to obtain probabilities of insulin resistance. A receiver operating characteristic analysis was conducted to evaluate the ability of TG/HDL-C to discriminate insulin resistance.

Results

TG/HDL-C was associated with insulin resistance in Chinese patients with newly diagnosed T2DM (Spearman’s correlation coefficient = 0.21, P < 0.01). Patients in the higher tertiles of TG/HDL-C had significantly higher HOMA-IR values than patients in the lower tertiles [T1: 2.68(1.74–3.70); T2: 2.96(2.29–4.56); T3: 3.09(2.30–4.99)]. Multiple logistic regression analysis showed that TG/HDL-C was significantly associated with HOMA-IR, and patients in the higher TG/HDL-C tertile had a higher OR than those in the lower TG/HDL-C tertile, after adjusting for multiple covariates including indices for central obesity [T1: 1; T2: 4.02(1.86–8.71); T3: 4.30(1.99–9.29)]. Following stratification of waist circumference into quartiles, the effect of TG/HDL-C on insulin resistance remained significant irrespective of waist circumference.

Conclusions

TG/HDL-C was associated with insulin resistance independent of waist circumference. Whether it could be a surrogate marker for insulin resistance in Chinese patients with newly diagnosed type 2 diabetes mellitus still needs to be confirmed by more researches.

Introduction

Type 2 diabetes mellitus (T2DM) is a progressive disease, characterized by insulin resistance and ongoing loss of endogenous insulin secretion [1]. More and more people are affected by T2DM in recent years. It was reported that the overall prevalence of diabetes in the Chinese adult population was estimated to be 11.6% and the prediabetes was 50.1% in 2013 [2]. T2DM is the most common form of diabetes for Chinese populations, which accounts for more than 90% of all diagnosed diabetes mellitus cases [3]. As insulin resistance is important in the pathogenesis of T2DM, it is helpful to identify early insulin resistance.

The gold standard method for insulin resistance is glucose clamp technique firstly requested by DeFronzo [4]. However, it is complex, time-consuming and invasive, making it not feasible for routine clinical applications. Therefore, large numbers of surrogate indicators have been investigated for insulin resistance. Previous studies have demonstrated that insulin resistance identified by homeostasis model assessment (HOMA-IR) is strongly associated with glucose clamp-assessed insulin resistance [5–7]. This model utilizes a set of empirically derived equations based on the homeostatic concentration of fasting serum insulin (FINS) and fasting plasma glucose (FPG), which reflect the varying degrees of pancreatic β-cell function and insulin resistance [8].

Although HOMA-IR scores are useful indicators of insulin resistance for research purposes, they are expensive and are not readily available to clinicians. Thus, early identification of insulin resistance, preferably by using simple and inexpensive diagnostic tools, is essential for preventing and detecting T2DM. Triglyceride (TG) to high-density lipoprotein cholesterol (HDL-C) ratio has been proposed as a simple marker of insulin resistance [9–14]. The potential utility of TG/HDL-C to detect insulin resistance was firstly reported by McLaughlin in a Caucasian population [10]. Similar results were found in different racial groups such as Korean [15], non-Hispanic Black and Mexican American [16]. However, studies showed that TG/HDL-C might not be a marker of insulin resistance for African populations [17–20]. It is possible that given the racial variations in both TG and HDL-C levels, the association between TG/HDL-C and insulin resistance is ethnicity-dependent. There are limited evidences supporting that the ratio of TG/HDL-C is a surrogate marker of insulin resistance in Chinese individuals [14, 21–23]. What’s more, few studies have been conducted in newly diagnosed T2DM patients. Thus, this study focused on the plasma lipid profiles and explored the association between TG/HDL-C and insulin resistance in Chinese patients with newly diagnosed T2DM.

Methods

Study populations

Participants were recruited when they were diagnosed with T2DM for the first time at Renji Hospital located in Shanghai, China between January 2008 and December 2009. The diagnostic criteria for diabetes mellitus was the one that promulgated by World Health Organization (WHO) in 1999 [24]. Newly diagnosed T2DM patients who had never taken medicine for prediabetes and dyslipidemia diseases were enrolled in the study. Exclusion criteria included (1) the presence of diabetes or other chronic diseases such as heart and kindey diseases, (2) the use of medications that may affect blood pressure, glucose, or lipid metabolism, (3) thyroid and other endocrine diseases, (4) serious infections and trauma, (5) stress (6) and the informed consent form not being signed. The correlation coefficient between the TG/HDL -C ratio and HOMA-IR was 0.33–0.41 in a Chinese population [23]. The study’s target sample size was at least 92 or 58 by using Power Analysis and Sample Size 11 (PASS 11, a professional software for sample size calculation in clinical trials). 560 patients (272 men and 288 women) with newly diagnosed T2DM were involved in this study. Patients were divided into three groups according to tertiles of TG/HDL-C: T1: 0.12–0.95 (n = 186); T2: 0.96–1.70 (n = 186); T3: 1.71–10.14 (n = 188). All work was carried out in compliance with the declaration of Helsinki. The study protocol was approved by the Ethical Committee of Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China (Number: Renjikls N026). All participants provided written informed consent prior to enrollment.

Data collection

Anthropometric measurements including height, weight, waist circumference (WC) and hip circumference (HC) were measured by the WHO recommended protocols [25]. Body mass index (BMI) was calculated using the ratio of weight/height 2 (kg/m2). Waist to hip ratio (WHR) and waist to height ratio (WHtR) were calculated as WC divided by HC and height, respectively. Blood pressure (BP) was measured three times and the average of the three consecutively measurement was calculated [26]. All the patients were asked to be on a low-fat diet and avoid strenuous exercise before being taken blood samples. Following a 12-hour overnight fast, blood samples were collected from the antecubital vein of patients. Various biochemical markers including alanine transaminase (ALT), glycated hemoglobin A1c (HbA1c), total cholesterol (TC), TG, HDL-C, low-density lipoprotein cholesterol (LDL-C) were obtained. Standard oral glucose tolerance tests (75 g glucose load) and insulin releasing tests were conducted. Levels of plasma glucose and serum insulin were detected at 0, 30, 60, 120, 180 minutes of the tests. G0, G30, G60, G120, G180 symbolized the plasma glucose levels of the corresponding time. Similarly, INS0, INS30, INS60, INS120, INS180 denoted the serum insulin levels. G0 stood for FPG, and INS0 was on behalf of FINS.

Insulin resistance was determined using HOMA-IR. The following equation was used for HOMA-IR index: INS0 (IU/L) ×G0 (mmol/L)/22.5 [8]. Based on an epidemiology survey in China, insulin resistance was defined as HOMA-IR > 2.69 [27]. Homeostatic model assessment of β-cell function (HOMA-β) was from this equation: 20 ×INS0 (IU/L)/(G0 (mmol/L)-3.5) [6]. Insulin sensitivity was evaluated by insulin sensitivity index (ISI) composite: 10,000/([G0 × INS0] × [mean G0-120 × mean INS0-120] (mean G0-120 refers to the average plasma glucose level for the first 120 minutes calculated by the average value of G0, G30, G60 and G120) [28]. Early insulin secretion was calculated based on the formula for insulinogenic index (IGI, ΔINS30/ΔG30): (INS30-INS0) (IU/L)/(G30-G0) (mmol/L) [29].

Statistical analysis

Descriptive statistics for continuous variables were presented as mean ± standard deviation if variables were normally distributed, or as median and interquartile range (25%-75%) for skewed variables. Independent-samples t test and one-way analysis of variance test were adopted for normally distributed data. If the data showed a skewed distribution, Mann-Whitney U test and Kruskal-Wallis H test were taken for differences. Pearson’s correlations were looked into to measure the associations between TG/HDL-C and other variables when they were normally distributed, if not, Spearman’s correlations were adopted. To figure out the clinical utility of TG/HDL-C in predicting insulin resistance, the receiver operating characteristic (ROC) curve was plotted and the area under the curve was calculated.

The primary focus of the analysis was to investigate the association between insulin resistance and TG/HDL-C values as risk factors for T2DM. For the odds ratios (ORs) and 95% confidence intervals (95% CIs) of TG/HDL-C for insulin resistance, the stepwise logistic regression analyses were performed to examine the relationship between insulin reisistance as the dependent variable and TG/HDL-C, by controlling for confounding variables including sex, age, SBP, BMI, ALT, and HbA1c. The previous study indicated central obesity was a risk factor for insulin resistance [30]. Hence, we added indicators which stood for central obesity including WC, WHR and WHtR in the models. To further evaluate the interactive effect of the TG/HDL-C ratio by WC on insulin resistance, WC was stratified into four groups based on quartiles. The quartiles of WC were categorised as follows: Q1: 63.0–83.0cm; Q2: 83.1–90.0cm; Q3: 90.1–98.0cm; Q4:98.1–121.0cm. Multiple logistic regression analysis was employed to analyze the interactions among WC, TG/HDL-C and insulin resistance. Each combination was compared to the composite of the first tertile of TG/HDL-C and the first quartile of WC.

All statistical analyses were performed using the SPSS statistical package (version 20.0, SPSS Inc, USA). All statistical tests were two-sided, and a P-value < 0.05 was considered statistically significant.

Results

Comparisons of the general characteristics among patients of newly diagnosed T2DM with different tertiles of TG/HDL-C

Clinical data and baseline characteristics of patients with different tertiles of TG/HDL-C are presented in Table 1. Patients in the higher tertiles of TG/HDL-C had higher DBP, BMI, WC, WHR, WHtR, TG, TC, Log(TG/HDL-C), HbA1c, FPG, FINS, and HOMA-IR than patients in the lower tertiles of TG/HDL-C, and the significant differences were mainly between T1 and T2, T1 and T3. Yet, HDL-C and ISI concentration decreased significantly. Mean values of SBP, HOMA-β, and IGI were not significantly different among different TG/HDL-C tertiles.

Table 1. Clinical and metabolic characteristics of patients according to TG/HDL-C tertiles.

Variables T1 (0.12–0.95) n = 186 T2 (0.96–1.70) n = 186 T3 (1.71–10.14) n = 188
Age (year) 56(50.50–62.50) 56(47.50–63) 54(45.25–60)*#
SBP (mmHg) 130(120–140) 130(120–140) 130(120–142)
DBP (mmHg) 80(72–89) 80(78.50–89.50)* 84(80–90)*
BMI (kg/m2) 24.13(22.24–26.42) 25.29(23.52–27.20)* 25.65(23.56–28.06)*
WC (cm) M87(79–93) F84(76–88) M91.5(88–97)* F86(79–92)* M92(88–96)* F86(81–94)*
WHR 0.88(0.85–0.93) 0.91(0.87–0.96)* 0.93(0.89–0.96)*
WHtR 0.52(0.48–0.55) 0.54(0.51–0.57)* 0.54(0.51–0.58)*
ALT (U/L) 21(15–33.25) 30.50(20–42.50)* 29(19–53)*
TG (mmol/L) 0.97(0.81–1.20) 1.58(1.36–1.85)* 2.67(2.17–3.35)*#
TC (mmol/L) 4.88(4.20–5.54) 5.13(4.49–5.80)* 5.13(4.46–5.87)*
LDL-C (mmol/L) 2.97(2.46–3.46) 3.33(2.82–3.81)* 3.23(2.67–3.72)*
HDL-C (mmol/L) 1.51(1.34–1.81) 1.28(1.13–1.42)* 1.07(0.96–1.24)*#
Log(TG/HDL-C) -0.17(-0.28–0.86) 0.10(0.03–0.15)* 0.37(0.28–0.50)*#
HbA1c (%) 6.55(5.98–7.50) 6.90(6.28–7.73)* 6.90(6.20–8.58)*
FPG (mmol/L) 6.70(6.10–7.53) 7.00(6.38–7.90) 7.10(6.23–8.52)*
2hPG (mmol/L) 13.30(11.48–15.55) 13.70(11.60–16.70) 13.90(11.63–17.20)
FINS (μIU/ml) 8.63(6.03–11.48) 9.68(7.39–13.59)* 10.14(7.17–14.56)*
2hPINS (μIU/ml) 42.61(26.17–75.62) 51.02(31.51–78.26) 50.95(25.90–84.90)
HOMA-IR 2.68(1.74–3.70) 2.96(2.29–4.56)* 3.09(2.30–4.99)*
HOMA-β 51.20(34–76.41) 58.17(35.18–87.11) 55.45(34.28–84.10)
ISI 0.53(0.29–1.05) 0.39(0.20–0.66)* 0.35(0.19–0.69)*
IGI 2.71(1.16–5.40) 3.13(1.07–5.68) 3.17(1.02–6.41)
Open in a new tab

Abbreviations: SBP:systolic blood pressure; DBP:diastolic blood pressure; BMI:body mass index; WC:waist circumference; M:male; F:female; WHR:waist to hip ratio; WHtR: waist to height ratio; ALT:alanine transaminase; TG:triglyceride; TC:total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL-C:high-density lipoprotein cholesterol; HbA1c: glycated hemoglobin A1c; FPG: fasting plasma glucose; 2hPG:2-hour postprandial plasma glucose; FINS:fasting serum insulin; 2hPINS:2-hour postprandial serum insulin; HOMA-IR:homeostatic model assessment of insulin resistance; HOMA-β:homeostatic model assessment of β-cell function; ISI:insulin sensitivity index; IGI: insulinogenic index.

* means comared to T1, P < 0.05.

# means compared to T2, P < 0.05.

Gender-adjusted Spearman’s correlations between other variables and TG/HDL-C

Gender-adjusted Spearman’s correlations between other variables and TG/HDL-C are shown in Table 2. TG and HDL-C were not analyzed as they were included in the formula of TG/HDL-C value. We just listed the data which were statistically significant. As is shown in Table 2, DBP, BMI, WC, WHR, HbA1c, Log(TG/HDL-C), FPG, FINS, HOMA-IR were positively associated with TG/HDL-C (Spearman’s correlation coefficient = 0.15, 0.21, 0.25, 0.26, 0.18, 1, 0.16, 0.16, 0.21, P < 0.01). Negative association was seen between ISI and TG/HDL-C (Spearman’s correlation coefficient = -0.18, P < 0.01). Some variables such as SBP, LDL-C, ALT and 2hPINS were positively associated with TG/HDL-C. Unfortunately, these associations were not statistically significant (data were not shown).

Table 2. Gender-adjusted Spearman’s correlations between TG/HDL-C and other variables.

Variables TG/HDL-C p
DBP 0.15 0.001
BMI 0.21 < 0.001
WC 0.25 < 0.001
WHR 0.26 < 0.001
HbA1c 0.18 < 0.001
Log(TG/HDL-C) 1
FPG 0.16 < 0.001
FINS 0.16 < 0.001
HOMAIR 0.21 < 0.001
ISI -0.18 < 0.001
Open in a new tab

Abbreviations: DBP:diastolic blood pressure; BMI:body mass index; WC:waist circumference; WHR:waist to hip ratio; HbA1c:glycated hemoglobin A1c; FPG: fasting plasma glucose; FINS:fasting serum insulin; HOMA-IR:homeostatic model assessment of insulin resistance; ISI:insulin sensitivity index.

Stepwise logistic regression analyses for insulin resistance

Stepwise logistic regression analyses designed to examine the relationship between the tertiles of TG/HDL-C and insulin resistance are listed in Table 3. The variables including sex, age, SBP, BMI, ALT, and HbA1c were adjusted for in the logistic regression analysis to calculate ORs in Model 1. In order to control central obesity, three more variables including WC, WHR and WHtR were added in Model 4 to investigate the effect of the TG/HDL-C ratio on insulin resistance. Patients in the higher TG/HDL-C tertile had a higher OR compared to those in the lower quartile [T1: 1; T2: 4.02(1.86–8.71); T3: 4.30(1.99–9.29)]. All these ORs were statistically significant. Moreover, our data demonstrated that WC and WHR might be important interference factors because they were still in the regression equation at last.

Table 3. Multivariable-adjusted odds ratios for insulin resistance according to each tertile of TG/HDL-C.

TG/HDL-C T1(0.12–0.95) T2(0.96–1.70) T3(1.71–10.14)
Model 1 OR(95% CI) 1 3.00(1.50–6.02) 3.11(1.56–6.22)
Model 2 OR(95% CI) 1 3.30(1.58–6.89) 3.53(1.68–7.41)
Model 3 OR(95% CI) 1 4.02(1.86–8.71) 4.30(1.99–9.29)
Model 4 OR(95% CI) 1 4.02(1.86–8.71) 4.30(1.99–9.29)
Open in a new tab

Model 1: Adjusted for sex, age, SBP, BMI, ALT, HbA1c.

Model 2: Adjusted for WC, in addition to the factors in Model 1.

Model 3: Adjusted for WHR, in addition to the factors in Model 2.

Model 4: Adjusted for WHtR, in addition to the factors in Model 3.

Abbreviations: TG/HDL-C:triglyceride to high-density lipoprotein cholesterol ratio; T:tertile. SBP:systolic blood pressure; BMI:body mass index; ALT:alanine transaminase; HbA1c:glycated hemoglobin A1c; WC:waist circumference; WHR:waist to hip ratio; WHtR: waist to height ratio.

ROC curves of TG/HDL-C, TG and HDL-C for insulin resistance

In order to compare the efficiency for insulin resistance among TG/HDL-C, TG and HDL-C, the ROC curves were plotted (see in Fig 1). For the TG/HDL-C ratio, an incremental increase in true-positive rates (sensitivity) was associated with relatively smaller increases in false positive rates (1-specificity) as compared with the curves of TG or HDL-C. In addition, the TG/HDL-C ratio presented the greatest value of the area under the ROC curve with statistical significance [TG/HDL-C:0.70 ± 0.03(0.65–0.75); TG: 0.69 ± 0.03(0.64–0.74); HDL-C: 0.37 ± 0.03(0.31–0.42)].

Fig 1. Receiver operating characteristic (ROC) curves of TG/HDL-C, TG, and HDL-C for insulin resistance.

Fig 1

Open in a new tab

The area under the ROC curve ± standard error (95% CI):TG/HDL-C: 0.70 ± 0.03(0.65–0.75); TG: 0.69 ± 0.03(0.64–0.74); HDL-C: 0.37 ± 0.03(0.31–0.42). Abbreviations: TG:triglyceride; HDL-C:high-density lipoprotein cholesterol; TG/HDL-C:triglyceride to high-density lipoprotein cholesterol ratio.

Combinations of TG/HDL-C tertiles and WC quartiles to examine the interactive effect on insulin resistance

We combined TG/HDL-C tertiles and WC quartiles which were cross-tabulated to examine the interactive effect on insulin resistance (see in Fig 2). Each composite had a higher OR than the combination of the first tertile of TG/HDL-C and the first quartile of WC. Provided that the OR of the first combination was one, more than half of the ORs were larger than ten. The figure showed that TG/HDL-C had an increasing association with insulin resistance in any WC quartile except WC Q4, and all the data were statistically significant. In addition, given the same TG/HDL-C tertile such as T3, the ORs of WC for insulin resistance presented an increasing pattern of association.

Fig 2. The relationship with insulin resistance of each combination of TG/HDL-C tertiles and WC quartiles.

Fig 2

Open in a new tab

Each block of OR represents the OR as against the OR which the patients belonging to the first tertile of TG/HDL-C and the first quartile of WC. Abbreviations: WC:waist circumference; T:tertile; Q:quartile.

Discussion

In this study, we found that TG/HDL-C was associated with insulin resistance in Chinese patients with newly diagnosed T2DM. The association still existed regardless of WC, WHR and WHtR after adjusting for sex, age, SBP, BMI, ALT, and HbA1c. Furthermore, HOMA-IR increased with the rising TG/HDL-C levels. In Giannini’s study, modest correlations were found between the TG/HDL-C ratio and insulin sensitivity measured by the hyperinsulinemic-euglycemic clamp, what’s more, TG/HDL-C was a more meaningful indicator than HOMA-IR [31].

High TG and low HDL-C levels are known to be associated with insulin resistance and T2DM [32] and cardiovascular diseases (CVDs) [33]. In addition, they have been explored to be used for insulin resistance, but the discriminatory power of single TG or HDL-C was poor, and TG/HDL-C was a stronger risk factor [34]. This is consistent with our study. As is shown in Fig 1, TG/HDL-C had the largest area of ROC compared with TG and HDL-C, reaching diagnostic significance. This is similar to the results of Korean studies [15, 35]. Zhang et al. [23] got an 0.73 area of TG/HDL-C ROC in overweight/obese women, which was a little larger than ours. Although both of us studied on Chinese populations, distinct physical or health condition was the main difference. Giannini et al. [31] used the hyperinsulinemic-euglycemic clamp data as the gold standard of insulin sensitivity, the evaluation of TG/HDL-C was significant for the whole cohort regardless of ethnicity and sex (0.752 ± 0.042, P < 0.001).

Central obesity is one of the strongest indicators of insulin resistance. WC, WHR and WHtR are the useful measurements for central obesity, and WC is the most sensitive index [36]. It has been reported that individuals with higher WC have more visceral fat and are more susceptible to chronic diseases caused by insulin resistance than those with lower WC and the same BMI [37]. The effects of WC and other indices on insulin resistance should be considered when examining the relationship between the TG/HDL-C ratio and insulin resistance. Therefore, we added WHR, WHtR, and WC to the models one by one. Table 3 is the tabulation of odds ratio (OR) across all tertiles of TG/HDL-C ratio in relation to insulin resistance. Patients in the higher TG/HDL-C tertile had a higher OR compared to those in the lower tertile. In order to eliminate the independent effect of WC on insulin resistance, stratification of WC was conducted. Fig 2 shows that TG/HDL-C was still allowed to maintain statistically significant relationship with insulin resistance. All the other eleven combinations had a higher OR than the combination of first tertile of TG/HDL-C and the first quartile of WC. Where, at a given WC quartile, patients in the higher tertile of the TG/HDL-C ratio were more likely to be insulin resistant in relation to those in the lower quartiles except the last quartile of WC. Korean studies [15, 35] adopted the stratification of WC to dispel its effect on insulin resistance as well. One also had exceptional conditions which were analogous to ours [15]. The other indicated that participants in the higher quartile of TG/HDL-C had a higher OR than those in any lower quartile independent of WC [35]. That our sample is not large enough may account for this exception. As is shown in Fig 2, patients in the third tertile of TG/HDL-C were found to be so strongly associated with the prevalence of insulin resistance, that these ORs were about thrice the values of these in T1. Moreover, in some given WC quartile, the ratio reached more than nine.

In our previous clinical studies, we found increased plasma triglyceride levels were associated with T2DM, which contributed to cardiovascular diseases [38, 39]. Lipoprotein lipase gene mutations may play an important role in dyslipidemia in T2DM patients [38]. Elevated insulin resistance and TGs are both independently and inversely relevant to reduced HDL-C [40]. The TG/HDL-C ratio may serve as a more appropriate value of insulin resistance when predicting CVD-related morbidity and mortality [41–43]. Dobiasova et al. [44] revealed that Log(TG/HDL-C) had a strong association with the diameter of LDL-C particle, and named it atherogenic index of plasma (AIP), suggesting it as an indirect index for the diameter of LDL-C particle. As the TG/HDL-C ratio increases, LDL-C particles become smaller and denser, which contribute to the development of atherosclerosis and CVDs [45–48]. Barter et al. [49] demonstrated that higher levels of TG/HDL-C ratio were correlated with greater potential for developing CVDs through insulin resistance and more atherogenic LDL-C particles, even when LDL-C levels were in the normal range. A American study [50] revealed that individuals with higher TG/HDL-C had significantly higher BP, a more adverse lipid profile and was more insulin resistant as assessed by HOMA-IR. They drew the conclusions that TG/HDL-C provided a simple approach to identify individuals at a accentuated cardio-metabolic risk within a population of perceived increased risk of T2DM. In our study, we found that with the increasing tertile, DBP ascended as well. In addition, positive association was found between DBP and TG/HDL-C. Patients in the higher tertile had a more unfavorable lipid profile, especially for TG and HDL-C, which were consistent with Armato’s study [50]. Given the many syndromes associated with insulin resistance, including T2DM and coronary heart diseases, an elevated TG/HDL-C ratio supports more aggressive efforts to enhance insulin sensitivity.

We found that as TG/HDL-C increased, FPG and FINS increased as well. This bore an analogy to the result from Hirschler et al. [11]. 2hPG was increasing, but the differences were not statistically important. 2hPINS presented an increasing curve but decreased in the third tertile. As TG/HDL-C increased, HOMA-IR increased and ISI decreased. A American study also found that across the tertile groups, ISI significantly decreased and HOMA-IR significantly increased [31]. Patients in T2 and T3 groups reached insulin resistance according to the average level of HOMA-IR. As is shown in Table 2, FPG and FINS were positively associated with TG/HDL-C ratio. In our study, we found HOMA-β among different TG/HDL-C tertiles presented a wave, and IGI was on the rise. However, differences did not have statistical significance. These were similar to our another study [51]. Simental-Mendia et al. [52] promulgated that elevated TG levels were associated with HOMA-IR and HOMA-β indices in healthy children and adolescents with normal weight in Mexico, HOMA-β decreased as the TG/HDL-C ratio increased. Hermans et al. [53] reported that log(TG)/HDL-C was related to both residual cardio-metabolic risk and β-cell function loss in males with type 2 diabetes mellitus. These results were different from those of ours. Some causes led to these differences. Their studying subjects were from different races compared with ours, in addition, their patients were with normal weight. Besides, our patients were newly diagnosed with T2DM, the function of pancreatic β-cell was still in the compensatory phase.

There are certain limitations that should be noted here. Firstly, the sample of the present study was not large enough and the patients were from the areas surrounding Shanghai city, thus it can not symbolize the general situation. Secondly, we did not supply the comparison of TG/HDL-C with the gold standard. Last but not least, we didn’t offer the cut-off of TG/HDL-C for insulin resistance.

Conclusions

In conclusion, this study demonstrated that TG/HDL-C was associated with insulin resistance in Chinese patients with newly diagnosed T2DM. After adjusting for confounding variables, the association still existed regardless of BMI, WC, WHR and WHtR. HOMA-IR went up with the increase of TG/HDL-C. In addition, the TG/HDL-C ratio may serve as a more appropriate value of insulin resistance when predicting CVD-related morbidity and mortality. Whether this criterion (TG/HDL-C) could be an easy and inexpensive marker of insulin resistance for newly diagnosed T2DM still needs to be confirmed by more researches.

Supporting Information

S1 File. This file contains the original data.

(XLS)

Click here for additional data file. (531.5KB, xls)

Acknowledgments

We want to thank the staff of the Endocrinology and Metabolism Laboratory and the nursing staff for their dedicated assistance in patient sample collection.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

This work was supported by National Scientific Foundation of China (No. 81270946, 81170758, 30670988), http://www.nsfc.gov.cn/; Foundation from Renji Hospital, Shanghai Jiaotong University (RJZZ14-003), http://www.renji.com/index.aspx, receiver: Yaomi Hu. All sponsors or funders played a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.

References

  • 1.Festa A, Williams K, D'Agostino R Jr., Wagenknecht LE, Haffner SM. The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes. 2006;55(4):1114–20. [DOI] [PubMed] [Google Scholar]
  • 2.Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al. Prevalence and control of diabetes in Chinese adults. Jama. 2013;310(9):948–59. 10.1001/jama.2013.168118 [DOI] [PubMed] [Google Scholar]
  • 3.Wang H, Hu C. Association of tagging SNPs in the MTHFR gene with risk of type 2 diabetes mellitus and serum homocysteine levels in a Chinese population. 2014;2014:725731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. The American journal of physiology. 1979;237(3):E214–23. [DOI] [PubMed] [Google Scholar]
  • 5.Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes care. 2000;23(1):57–63. [DOI] [PubMed] [Google Scholar]
  • 6.Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9. [DOI] [PubMed] [Google Scholar]
  • 7.Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes care. 2000;23(2):171–5. [DOI] [PubMed] [Google Scholar]
  • 8.Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes care. 2004;27(6):1487–95. [DOI] [PubMed] [Google Scholar]
  • 9.Kimm H, Lee SW, Lee HS, Shim KW, Cho CY, Yun JE, et al. Associations between lipid measures and metabolic syndrome, insulin resistance and adiponectin.—Usefulness of lipid ratios in Korean men and women. Circulation journal: official journal of the Japanese Circulation Society. 2010;74(5):931–7. [DOI] [PubMed] [Google Scholar]
  • 10.McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Annals of internal medicine. 2003;139(10):802–9. [DOI] [PubMed] [Google Scholar]
  • 11.Hirschler V, Maccallini G, Sanchez M, Gonzalez C, Molinari C. Association between triglyceride to HDL-C ratio and insulin resistance in indigenous Argentinean children. Pediatric diabetes. 2015;16(8):606–12. 10.1111/pedi.12228 [DOI] [PubMed] [Google Scholar]
  • 12.Rajappa M, Sridhar MG, Balachander J, Sethuraman KR, Rajendiran KS. Lipoprotein ratios as surrogate markers for insulin resistance in South indians with normoglycemic nondiabetic acute coronary syndrome. ISRN endocrinology. 2014;2014:981524 10.1155/2014/981524 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ray S, Bairagi AK, Guha S, Ganguly S, Ray D, Basu AK, et al. A simple way to identify insulin resistance in non-diabetic acute coronary syndrome patients with impaired fasting glucose. Indian journal of endocrinology and metabolism. 2012;16(Suppl 2):S460–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Chiang JK, Lai NS, Chang JK, Koo M. Predicting insulin resistance using the triglyceride-to-high-density lipoprotein cholesterol ratio in Taiwanese adults. Cardiovascular diabetology. 2011;10:93 10.1186/1475-2840-10-93 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kim JS, Kang HT, Shim JY, Lee HR. The association between the triglyceride to high-density lipoprotein cholesterol ratio with insulin resistance (HOMA-IR) in the general Korean population: based on the National Health and Nutrition Examination Survey in 2007–2009. Diabetes research and clinical practice. 2012;97(1):132–8. 10.1016/j.diabres.2012.04.022 [DOI] [PubMed] [Google Scholar]
  • 16.Li C, Ford ES, Meng YX, Mokdad AH, Reaven GM. Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity? Cardiovascular diabetology. 2008;7:4 10.1186/1475-2840-7-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kim-Dorner SJ, Deuster PA, Zeno SA, Remaley AT, Poth M. Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance? Metabolism: clinical and experimental. 2010;59(2):299–304. [DOI] [PubMed] [Google Scholar]
  • 18.Bovet P, Faeh D, Gabriel A, Tappy L. The prediction of insulin resistance with serum triglyceride and high-density lipoprotein cholesterol levels in an East African population. Archives of internal medicine. 2006;166(11):1236–7. [DOI] [PubMed] [Google Scholar]
  • 19.Reaven G, McLaughlin T. Why the plasma TG/HDL-C concentration ratio does not predict insulin resistance in African Americans. Archives of internal medicine. 2006;166(2):249; author reply -50. [DOI] [PubMed] [Google Scholar]
  • 20.Sumner AE, Finley KB, Genovese DJ, Criqui MH, Boston RC. Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans. Archives of internal medicine. 2005;165(12):1395–400. [DOI] [PubMed] [Google Scholar]
  • 21.Gasevic D, Frohlich J, Mancini GB, Lear SA. The association between triglyceride to high-density-lipoprotein cholesterol ratio and insulin resistance in a multiethnic primary prevention cohort. Metabolism: clinical and experimental. 2012;61(4):583–9. [DOI] [PubMed] [Google Scholar]
  • 22.He J, He S, Liu K, Wang Y, Shi D, Chen X. The TG/HDL-C Ratio Might Be a Surrogate for Insulin Resistance in Chinese Nonobese Women. 2014;2014:105168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Zhang L, Chen S, Deng A, Liu X, Liang Y, Shao X, et al. Association between lipid ratios and insulin resistance in a Chinese population. PloS one. 2015;10(1):e0116110 10.1371/journal.pone.0116110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Colman PG, Thomas DW, Zimmet PZ, Welborn TA, Garcia-Webb P, Moore MP. New classification and criteria for diagnosis of diabetes mellitus. The Australasian Working Party on Diagnostic Criteria for Diabetes Mellitus. The New Zealand medical journal. 1999;112(1086):139–41. [PubMed] [Google Scholar]
  • 25.Molarius A, Seidell JC, Sans S, Tuomilehto J, Kuulasmaa K. Waist and hip circumferences, and waist-hip ratio in 19 populations of the WHO MONICA Project. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity. 1999;23(2):116–25. [DOI] [PubMed] [Google Scholar]
  • 26.Chen S, Chen Y, Liu X, Li M, Wu B, Li Y, et al. Association of insulin resistance with chronic kidney disease in non-diabetic subjects with normal weight. PloS one. 2013;8(9):e74058 10.1371/journal.pone.0074058 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Xing XYZW, Yang ZJ. The diagnostic significance of homeostasis model assessment of insulin resistance in Metabolic Syndrome among subjects with different glucose tolerance (Chinese). Chin J Diabetes. 2004;12(3):182–6. [Google Scholar]
  • 28.Aoyama-Sasabe S, Xin X, Taniguchi A, Nakai Y, Mitsui R, Tsuji H, et al. Relationship and factors responsible for regulating fasting and post-challenge plasma glucose levels in the early stage development of type 2 diabetes mellitus. Journal of diabetes investigation. 2014;5(6):663–70. 10.1111/jdi.12239 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Phillips DI, Clark PM, Hales CN, Osmond C. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabetic medicine: a journal of the British Diabetic Association. 1994;11(3):286–92. [DOI] [PubMed] [Google Scholar]
  • 30.Chen S, Chen Y, Liu X, Li M, Wu B, Li Y, et al. Insulin resistance and metabolic syndrome in normal-weight individuals. Endocrine. 2014;46(3):496–504. 10.1007/s12020-013-0079-8 [DOI] [PubMed] [Google Scholar]
  • 31.Giannini C, Santoro N, Caprio S, Kim G, Lartaud D, Shaw M, et al. The triglyceride-to-HDL cholesterol ratio: association with insulin resistance in obese youths of different ethnic backgrounds. Diabetes care. 2011;34(8):1869–74. 10.2337/dc10-2234 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes. 1998;47(10):1643–9. [DOI] [PubMed] [Google Scholar]
  • 33.Sun GZ, Li Z, Guo L, Zhou Y, Yang HM, Sun YX. High prevalence of dyslipidemia and associated risk factors among rural Chinese adults. Lipids in health and disease. 2014;13:189 10.1186/1476-511X-13-189 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.He S, Wang S, Chen X, Jiang L, Peng Y, Li L, et al. Higher ratio of triglyceride to high-density lipoprotein cholesterol may predispose to diabetes mellitus: 15-year prospective study in a general population. Metabolism: clinical and experimental. 2012;61(1):30–6. [DOI] [PubMed] [Google Scholar]
  • 35.Kang HT, Yoon JH, Kim JY, Ahn SK, Linton JA, Koh SB, et al. The association between the ratio of triglyceride to HDL-C and insulin resistance according to waist circumference in a rural Korean population. Nutrition, metabolism, and cardiovascular diseases: NMCD. 2012;22(12):1054–60. 10.1016/j.numecd.2011.01.013 [DOI] [PubMed] [Google Scholar]
  • 36.Bacopoulou F, Efthymiou V, Landis G, Rentoumis A, Chrousos GP. Waist circumference, waist-to-hip ratio and waist-to-height ratio reference percentiles for abdominal obesity among Greek adolescents. BMC pediatrics. 2015;15:50 10.1186/s12887-015-0366-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Tanaka S, Horimai C, Katsukawa F. Ethnic differences in abdominal visceral fat accumulation between Japanese, African-Americans, and Caucasians: a meta-analysis. Acta diabetologica. 2003;40 Suppl 1:S302–4. [DOI] [PubMed] [Google Scholar]
  • 38.Hu Y, Ren Y, Luo RZ, Mao X, Li X, Cao X, et al. Novel mutations of the lipoprotein lipase gene associated with hypertriglyceridemia in members of type 2 diabetic pedigrees. Journal of lipid research. 2007;48(8):1681–8. [DOI] [PubMed] [Google Scholar]
  • 39.Hu Y, Liu W, Huang R, Zhang X. A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases. Journal of lipid research. 2006;47(9):1908–14. [DOI] [PubMed] [Google Scholar]
  • 40.Haffner SM, D'Agostino R Jr., Mykkanen L, Tracy R, Howard B, Rewers M, et al. Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes care. 1999;22(4):562–8. [DOI] [PubMed] [Google Scholar]
  • 41.Hadaegh F, Khalili D, Ghasemi A, Tohidi M, Sheikholeslami F, Azizi F. Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Nutrition, metabolism, and cardiovascular diseases: NMCD. 2009;19(6):401–8. 10.1016/j.numecd.2008.09.003 [DOI] [PubMed] [Google Scholar]
  • 42.Bittner V, Johnson BD, Zineh I, Rogers WJ, Vido D, Marroquin OC, et al. The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE). American heart journal. 2009;157(3):548–55. 10.1016/j.ahj.2008.11.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Cordero A, Andres E, Ordonez B, Leon M, Laclaustra M, Grima A, et al. Usefulness of triglycerides-to-high-density lipoprotein cholesterol ratio for predicting the first coronary event in men. The American journal of cardiology. 2009;104(10):1393–7. 10.1016/j.amjcard.2009.07.008 [DOI] [PubMed] [Google Scholar]
  • 44.Dobiasova M, Frohlich J. [The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy]. Vnitrni lekarstvi. 2000;46(3):152–6. [PubMed] [Google Scholar]
  • 45.Maruyama C, Imamura K, Teramoto T. Assessment of LDL particle size by triglyceride/HDL-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia. Journal of atherosclerosis and thrombosis. 2003;10(3):186–91. [DOI] [PubMed] [Google Scholar]
  • 46.Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. Jama. 1996;276(11):875–81. [PubMed] [Google Scholar]
  • 47.Coresh J, Kwiterovich PO Jr. Small, dense low-density lipoprotein particles and coronary heart disease risk: A clear association with uncertain implications. Jama. 1996;276(11):914–5. [PubMed] [Google Scholar]
  • 48.Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation. 1997;95(1):69–75. [DOI] [PubMed] [Google Scholar]
  • 49.Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. The New England journal of medicine. 2007;357(13):1301–10. [DOI] [PubMed] [Google Scholar]
  • 50.Armato J, Reaven G, Ruby R. Triglyceride/High-Density Lipoprotein Cholesterol Concentration Ratio Identifies Accentuated Cardio-Metabolic Risk. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2015:1–18. [DOI] [PubMed] [Google Scholar]
  • 51.Zheng S, Zhou H, Han T, Li Y, Zhang Y, Liu W, et al. Clinical characteristics and beta cell function in Chinese patients with newly diagnosed type 2 diabetes mellitus with different levels of serum triglyceride. BMC endocrine disorders. 2015;15:21 10.1186/s12902-015-0018-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Simental-Mendia LE, Castaneda-Chacon A, Rodriguez-Moran M, Aradillas-Garcia C, Guerrero-Romero F. Relationship between elevated triglyceride levels with the increase of HOMA-IR and HOMA-beta in healthy children and adolescents with normal weight. European journal of pediatrics. 2015;174(5):597–605. 10.1007/s00431-014-2426-z [DOI] [PubMed] [Google Scholar]
  • 53.Hermans MP, Ahn SA, Rousseau MF. log(TG)/HDL-C is related to both residual cardiometabolic risk and beta-cell function loss in type 2 diabetes males. Cardiovascular diabetology. 2010;9:88 10.1186/1475-2840-9-88 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 File. This file contains the original data.

(XLS)

Click here for additional data file. (531.5KB, xls)

Data Availability Statement

All relevant data are within the paper and its Supporting Information files.

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES